Conference abstractPublished 15 Mar 2017
Magnetic Resonance Spectroscopic Imaging in Pediatric Brain Tumors
Harvard Medical School, Boston
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Magnetic resonance (MR) techniques offer a noninvasive, non-irradiating yet sensitive approach to diagnose and monitor pediatric brain tumors. Proton MR spectroscopy (MRS), as an adjunct to MRI, has been more widely applied to monitor the metabolic aspects of brain cancer. In vivo MRS biomarkers represent a promising advance and may influence treatment choice both at initial diagnosis and follow-up, given the inherent difficulties of sequential biopsies to monitor therapeutic response. When combined with anatomical or other types of imaging, MRS provide unique information regarding biochemistry in inoperable brain tumors and may complement neuropathologic data, guide biopsies and suggest therapeutic options. The combination of non-invasively acquired prognostic information and the high-resolution anatomical imaging provided by conventional MRI is expected to surpass molecular analysis or DNA microarray gene profiling, both of which, although promising, depend on invasive biopsy. This presentation will focus on recent bibliographic data in the field of MRS in children with brain tumors.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectChemistry
- SubjectNeuroscience & Neurology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “A. Aria Tzika”